A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers
Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to determine the effects of Imrecoxib, an
anti-infiammatory/analgesic agent that primarily inhibits COX-2 and not COX-1 at therapeutic
doses, on the steady-state pharmacokinetic profile and hypoprothrombinemic effect of warfarin
in healthy volunteers.